Filing Details
- Accession Number:
- 0001209191-14-064571
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-23 18:46:31
- Reporting Period:
- 2014-10-21
- Filing Date:
- 2014-10-23
- Accepted Time:
- 2014-10-23 18:46:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604464 | Atara Biotherapeutics Inc. | ATRA | Biological Products, (No Disgnostic Substances) (2836) | 460920988 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1216955 | S Joel Marcus | C/O Alexandria Real Estate Equities, Inc 385 East Colorado Boulevard, Suite 299 Pasadena CA 91101 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-10-21 | 256,410 | $0.00 | 256,410 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2014-10-21 | 501,945 | $0.00 | 758,355 | No | 4 | C | Indirect | See Footnote |
Common Stock | Acquisiton | 2014-10-21 | 150,000 | $11.00 | 908,355 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | See Footnote |
No | 4 | C | Indirect | See Footnote |
No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2014-10-21 | 256,410 | $0.00 | 256,410 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2014-10-21 | 501,945 | $0.00 | 501,945 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect | ||
0 | No | 4 | C | Indirect |
Footnotes
- The Series A Preferred Stock had no expiration date and each share of Series A Preferred Stock was automatically converted into common stock on a 1-for-1 basis upon the consummation of the Issuer's initial public offering.
- Consists of shares of common stock held by Alexandria Equities, LLC. Mr. Marcus is the Chairman, CEO and Founder of Alexandria Real Estate Equities, Inc., which is the managing member of Alexandria Equities, LLC, which has full voting and investment power with respect to the shares owned by Alexandria Equities, LLC. As an officer of Alexandria Real Estate Equities, Inc., Mr. Marcus may be deemed to have voting and investment power with respect to the shares owned by Alexandria Equities, LLC. Mr. Marcus disclaims beneficial ownership of the shares held by Alexandria Equities, LLC, except to the extent of his underlying pecuniary interest therein.
- The Series B Preferred Stock had no expiration date and each share of Series B Preferred Stock was automatically converted into common stock on a 1-for-1 basis upon the consummation of the Issuer's initial public offering.